These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35259683)

  • 1. Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
    Leach JM; Cutter G; Golan D; Doniger G; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Sethi A; Covey T; Penner IK; Wilken J; Gudesblatt M
    Mult Scler Relat Disord; 2022 Apr; 60():103704. PubMed ID: 35259683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Brief Assessment of Cognitive Health (BACH) computerized screening tool in identifying MS-related cognitive impairment.
    Patrick KS; Chakrabati S; Rhoads T; Busch RM; Floden DP; Galioto R
    Mult Scler Relat Disord; 2024 Feb; 82():105398. PubMed ID: 38183694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study.
    Morrow SA; Balusha AAK; Rosehart H; Casserly C; Racosta JM
    Mult Scler Relat Disord; 2023 Dec; 80():105060. PubMed ID: 37866025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
    Magnin E; Sagawa Y; Moulin T; Decavel P
    Eur Neurol; 2020; 83(3):263-270. PubMed ID: 32634812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review.
    Ezegbe C; Zarghami A; van der Mei I; Alty J; Honan C; Taylor B
    Brain Behav; 2023 Jun; 13(6):e3009. PubMed ID: 37062948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory-Motor and Affective-Fatigue Factors are Associated with Symbol Digit Performance in Multiple Sclerosis.
    Arnett PA; Cadden M; Roman CAF; Guty E; Riegler K; Thomas G
    J Int Neuropsychol Soc; 2022 Apr; 28(4):362-370. PubMed ID: 34294175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.
    Maeta M; Mizuno M; Okubo S; Ogasawara M; Terauchi T; Suzuki M; Akasaka H; Sato Y; Ohi K; Maeda T
    Mult Scler Relat Disord; 2022 Dec; 68():104150. PubMed ID: 36055114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting employment deterioration with the Processing Speed Test (PST) and SDMT in multiple sclerosis.
    Jaworski MG; Gillies JK; Youngs M; Wojcik C; Santivasci C; Jakimovski D; Bergsland N; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2023 Sep; 29(10):1327-1336. PubMed ID: 37503838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?
    Galioto R; Macaron G; Lace JW; Ontaneda D; Rao SM
    Mult Scler Relat Disord; 2021 Sep; 54():103106. PubMed ID: 34217998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS.
    Patel VP; Shen L; Rose J; Feinstein A
    Mult Scler; 2019 Oct; 25(11):1506-1513. PubMed ID: 30079822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transcranial alternating current stimulation on cognitive function in people with multiple sclerosis: A randomized controlled trial.
    Hsu WY; Zanto T; Park JE; Gazzaley A; Bove RM
    Mult Scler Relat Disord; 2023 Dec; 80():105090. PubMed ID: 37925960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
    Jackson DA; Nicholson R; Bergmann C; Wilken J; Kaczmarek O; Bumstead B; Buhse M; Zarif M; Penner IK; Hancock LM; Golan D; Doniger GM; Bogaardt H; Barrera M; Covey TJ; Gudesblatt M
    Mult Scler Relat Disord; 2023 Jan; 69():104410. PubMed ID: 36399966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
    Akbar N; Honarmand K; Kou N; Feinstein A
    J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.
    Sandry J; Simonet DV; Brandstadter R; Krieger S; Katz Sand I; Graney RA; Buchanan AV; Lall S; Sumowski JF
    Mult Scler Relat Disord; 2021 Jun; 51():102950. PubMed ID: 33887609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.